АРИЛОКСИЭТИЛАМИНОВЫЕ И ФЕНИЛПИПЕРАЗИНОВЫЕ ПРОИЗВОДНЫЕ С СОЧЕТАНИЕМ СВОЙСТВ НЕПОЛНОГО АГОНИЗМА К РЕЦЕПТОРАМ ДОФИМИНА-D2 И ИНГИБИРОВАНИЯ ПОВТОРНОГО ПОГЛОЩЕНИЯ СЕРОТОНИНА

摘要

The invention relates to a group of novel phenylpiperazine derivatives with a dual mode of action: serotonin reuptake inhibition and partial agonism on dopamine -D2 receptors. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect. The compounds have the general formula (1) wherein the symbols have the meanings given in the specification.